Aging males' symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membership

Psychoneuroendocrinology

Volumn 35, Issue 4, 2010, Pages 578-587

  Schneider, Gudrun ^a   Nienhaus, Kathrin ^a   Gromoll, Jörg ^a   Heuft, Gereon ^a   Nieschlag, Eberhard ^a   Zitzmann, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aging male; Aging male symptoms; Androgen receptor polymorphism; CAG repeats; Estradiol; Late onset hypogonadism; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; SYMPTOM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ANDROGEN-INSENSITIVITY SYNDROME; CASE-CONTROL STUDIES; GONADAL STEROID HORMONES; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHOPHYSIOLOGIC DISORDERS; RECEPTORS, ANDROGEN; RESEARCH DESIGN; SAMPLING STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 77950689132     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.09.008     Document Type: Article

References (33)

1. Almeida O.P., Yeap B.B., Hankey G.J., Jamrozik K., Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch. Gen. Psychiatry 2008, 65:283-289.
2. Basar M.M., Aydin G., Mert H.C., Keles I., Caglayan O., Orkun S., Batislam E. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Adult Urol. 2005, 66:597-601.
3. Beutel M.E., Wiltink J., Hauck E.W., Auch D., Behre H.M., Brähler E., Weidner W. Correlations between hormones, physical and affective parameters in aging urologic outpatients. Eur. Urol. 2005, 47:749-755.
4. Canale D., Caglieresi C., Moschini C., Liberati C.D., Macchia E., Pinchera A., Martino E. Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin. Endocrinol. (Oxford) 2005, 63:356-361.
5. Daig I., Heinemann L.A.J., Kim S., Leungwattanakij S., Badia X., Myon E., Moore C., Saad F., Potthoff P., Thai D.M. The Aging Males Symptoms (AMS) scale: review of its methodological characteristics. Health Qual. Life Outcomes 2003, 1:77-89.
6. Delhez M., Hansenne M., Legros J.J. Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 2003, 28:863-874.
7. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Brenner W.J., McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 2002, 87:589-598.
8. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-Mental-State": a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 1975, 12:189-198.
9. Härkönen K., Huhtaniemi I., Mäkinen J., Hübler D., Irjala K., Koskenvuao M., Oettel M., Raitakari O., Saad F., Pöllänen P. The polymorphic androgen receptor gene CAG-repeat, pituitary-testicular function and andropausal symptoms in aging men. Int. J. Androl. 2003, 26:187-194.
10. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
11. Heinemann L.A., Saad F., Heinemann K., Thai D.M. Can results of the Aging Males Symptoms (AMS) scale predict those of screening scales for androgen deficiency?. Aging Male 2004, 7:211-218.
12. Heinemann L.A., Zimmermann T., Vermeulen A., Thiel C. A new " Aging Males Symptoms" (AMS) Rating Scale. The Aging Male 1999, 2:105-114.
13. Huhtaniemi I.T., Pye S.R., Limer K.L., Thomson W., O'Neill T.W., Platt H., Payne D., John S.L., Jiang M., Boonen S., Borghs H., Vanderschueren D., Adams J.E., Ward K.A., Bartfai G., Casanueva F., Finn J.D., Fort G., Givercman A., Han T.H., Kula K., Lean M.E.J., Pendleton N., Punab M., Silman A.J., Wu F.C.W. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J. Clin. Endocrinol. Metab. 2009, 94:277-284. The EMAS study group.
14. Kazi M., Geraci S., Koch C. Considerations for the diagnosis and treatment of testosterone deficiency in elderly men. Am. J. Med. 2007, 120:835-840.
15. Kratzik C.W., Reiter W.J., Riedl A.M., Lunglmayr G., Brandstatter N., Rucklinger E., Metka M., Huber J. Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna Municipality study. Aging Male 2004, 7:188-196.
16. Lütdke O., Tomasik M.J., Lang F. Participation rate and sample selectivity in age-comparative cross-sectional designs. Z. Entwicklungspsychologie und Psychologische Psychologie 2003, 35:171-180.
17. McIntyre R.S., Mancini D., Eisfeld B.S., Soczynska J.K., Grupp L., Konarski J.Z., Kennedy S.H. Calculated bioavailable testosterone levels and depression in middle aged men. Psychoneuroendocrinology 2006, 9:1029-1035.
18. Miwa Y., Kaneda T., Yokoyama O. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulphate, and growth hormone levels in ambulatory men. J. Sex. Med. 2006, 3:723-726.
19. Morley J.E., Charlton E., Patrick P., Kaiser F.E., Cadeau P., McCready D., Black A., Tremblay R. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000, 49:1239-1242.
20. Morsink L.F.J., Vogelzangs N., Nicklas B.J., Beekman A.T.F., Satterfield S., Rubin S.M., Yaffe K., Simonsick E., Newman A.B., Ktitchevsky S.B. Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology 2007, 32:874-883.
21. Perry P.J., Lund B.C., Arndt S., Holman T., Bever-Stille K., Paulsen J., Demers L.M. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann. Clin. Psychiatry 2001, 13:75-80.
22. Ponholzer A., Plas E., Schatzl G., Jungwirth A., Madersbacher S. Association of DHEA-S and estradiol serumlevels to symptoms of aging men. Aging Male 2002, 5:233-238.
23. Seidman S.N., Araujo A.B., Roose S.P., McKinlay J.B. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle aged men. Biol. Psychiatry 2001, 50:371-376.
24. T'Sjoen G., Goemare S., De Meyere M., Kaufman J.M. Perception of males aging symptoms is not related to circulating androgen levels. Psychoneuroendocrinology 2004, 29:201-214.
25. T'Sjoen G., De Vos S., Goemare S., van Pottelbergh I., Dierick M., van Heeringen C., Kaufman J.-M. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. JAGS 2005, 53:636-642.
26. Tancredi A., Reginster J.Y., Luyckx F., Legros J.J. No major month to month variation in free testosterone levels in aging males. Minor impact on the biological diagnosis of andropause. Psychoneuroendocrinology 2005, 30:638-646.
27. Wang C., Nieschlag E., Swerdloff R., Behre H.M., Hellstrom W.J., Gooren L.J., Kaufman J.M., Legros J.-J., Lunenfeld B., Morales A., Morley J.E., Schulman C., Thompson I.M., Weidner W., Wu F.C.W. ISA, ISSAM, EAU, EAA and ASA recommendations. Investigation, treatment and monitoring of late-onset hypogonadism in males. J. Androl. 2008, published-ahead-of-print on September 4.
28. Zitzmann M., Brune M., Kornmann B., von Eckardstein S., von Eckardstein A., Gromoll J., Nieschlag E. The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J. Clin. Endocrinol. Metab. 2001, 86:4867-4873.
29. Zitzmann M., Faber S., Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J. Clin. Endocrinol. Metab. 2006, 91:4335-4343.
30. Zitzmann M., Depenbusch M., Gromoll J., Nieschlag E. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J. Clin. Endocrinol. Metab. 2003, 88:2049-2054.
31. Zitzmann M., Gromoll J., von Eckardstein A., Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 2003, 46:31-39.
32. Zitzmann M., Nieschlag E. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur. J. Endocrinol. 2001, 144:183-197.
33. Zitzmann M., Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J. Clin. Endocrinol. Metab. 2007, 92:3844-3853.